What the FDA labels say about taking them together
Lithium and sotagliflozin
Sotagliflozin's FDA label of August 12, 2026 names lithium in its drug interactions section; the lithium labels PlainMeds reads (4) do not name sotagliflozin. The sotagliflozin label: “Consider monitoring of clinical status. Lithium: Monitor serum lithium concentrations.”
Check it at the source: the lithium FDA label on DailyMed (effective December 23, 2025, Glenmark Pharmaceuticals Inc., USA); the sotagliflozin FDA label on DailyMed (effective August 12, 2026, Lexicon Pharmaceuticals, Inc.).
What does the lithium label say about sotagliflozin?
Lithium's label (effective December 23, 2025) and its 3 other brand-application labels do not name sotagliflozin in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Lithium Carbonate), Glenmark Pharmaceuticals Inc., USA, effective December 23, 2025 (SPL set 63b3790f-a9b5-47f4-bae1-ddf8b43c13c1), via openFDA; the full label on DailyMed
What does the sotagliflozin label say about lithium?
Sotagliflozin label, drug interactionsConsider monitoring of clinical status. ( 7.2 ) Lithium: Monitor serum lithium concentrations.
Source: FDA drug label (INPEFA), Lexicon Pharmaceuticals, Inc., effective August 12, 2026 (SPL set 1a46614e-05f6-421a-b6f4-d6f8760d643a), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Lithium | Sotagliflozin | |
|---|---|---|
| Labeled for | Bipolar disorder | Heart failure |
| Boxed warning | Yes | No |
| Pharmacy cost (NADAC) | $0.104 per capsule 300 mg capsule | $20.37 per tablet 200 mg tablet |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once